Shop

“Article: O.3 Palliative cytoreduction with low dose intravenous melphalan in patients with acute myeloid leukemia refractory to prior treatment” has been added to your cart. View cart

Showing 1313–1328 of 2320 results

Article: O.2 A single analysis for simultaneous measurement of all 4 DOACs
€3.03 Add to cart
Article: O.2 Analysis of Phenotype and Outcome in Essential Thrombocythemia with CALR and JAK2 mutations
€3.03 Add to cart
Article: O.2 AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers
€3.03 Add to cart
Article: O.2 Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation
€3.03 Add to cart
Article: O.2 Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model
€3.03 Add to cart
Article: O.2 RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
€3.03 Add to cart
Article: O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS
€3.03 Add to cart
Article: O.3 Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood (PB) Stem Cell Transplantation (SCT) From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies
€3.03 Add to cart
Article: O.3 IgHV Mutational Status Analysis By Next-Generation Deep Sequencing In Chronic Lymphocytic Leukemia Patients: Prognostic Significance Of Multiple Subclones And Implication For Disease Cell Origin
€3.03 Add to cart
Article: O.3 Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an attractive Novel Drug Target in Multiple Myeloma and its associated Bone Disease
€3.03 Add to cart
Article: O.3 Palliative cytoreduction with low dose intravenous melphalan in patients with acute myeloid leukemia refractory to prior treatment
€3.03 Add to cart
Article: O.3 The anti-angiogenic peptide Anginex blocks osteoclastogenesis
€3.03 Add to cart
Article: O.4 An in-depth investigation of the causes of treatment failure in AML
€3.03 Add to cart
Article: O.4 Combination of regulatory T cells injection with rapamycin for treatment of chronic Graft-versus-Host disease
€3.03 Add to cart
Article: O.4 Functional characterization of activating mutants of the JAK3 tyrosine kinase implicated in tumoral transformation of T lymphocytes
€3.03 Add to cart
Article: O.4 Impact of pre-transplant infusion of antithymocyte globulin (ATG-Fresenius) on immune recovery after high intensity conditioning allogeneic stem cell transplantation
€3.03 Add to cart

Article: O.2 A single analysis for simultaneous measurement of all 4 DOACs

Article: O.2 Analysis of Phenotype and Outcome in Essential Thrombocythemia with CALR and JAK2 mutations

Article: O.2 AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers

Article: O.2 Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation

Article: O.2 Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model

Article: O.2 RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

Article: O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS

Article: O.3 Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood (PB) Stem Cell Transplantation (SCT) From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

Article: O.3 IgHV Mutational Status Analysis By Next-Generation Deep Sequencing In Chronic Lymphocytic Leukemia Patients: Prognostic Significance Of Multiple Subclones And Implication For Disease Cell Origin

Article: O.3 Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an attractive Novel Drug Target in Multiple Myeloma and its associated Bone Disease

Article: O.3 Palliative cytoreduction with low dose intravenous melphalan in patients with acute myeloid leukemia refractory to prior treatment

Article: O.3 The anti-angiogenic peptide Anginex blocks osteoclastogenesis

Article: O.4 An in-depth investigation of the causes of treatment failure in AML

Article: O.4 Combination of regulatory T cells injection with rapamycin for treatment of chronic Graft-versus-Host disease

Article: O.4 Functional characterization of activating mutants of the JAK3 tyrosine kinase implicated in tumoral transformation of T lymphocytes

Article: O.4 Impact of pre-transplant infusion of antithymocyte globulin (ATG-Fresenius) on immune recovery after high intensity conditioning allogeneic stem cell transplantation